Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7UG9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,206
Award facts
- Contract value 100% obligated
- $7,206.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,206.04 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on December 5, 2025, with an ultimate completion date of December 8, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive federal contract portfolio with DLA and the Defense Health Agency, supplying a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains. The parent IDC demonstrates the contractor's capability to meet federal medical procurement requirements through competitive award and supports critical medical supply chains for Department of Defense and veteran healthcare systems globally. This specific delivery order for Dupixent, a biologic immunosuppressant medication, represents one transaction within the broader framework of the prime vendor program that enables flexible pharmaceutical support across military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F7UG9?
SPE2DR26F7UG9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F7UG9 worth?
The government has obligated $7,206 on SPE2DR26F7UG9.
Is contract SPE2DR26F7UG9 an order under another contract?
Yes. SPE2DR26F7UG9 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7UG9 competed?
The extent of competition for SPE2DR26F7UG9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award